Skip to main content Skip to navigation

Hema Mistry

Job Title
Associate Professor
Department
WMS - Warwick Clinical Trials Unit
Phone
02476 151183
Research Interests

Economic evaluations alongside clinical trials; Evidence synthesis; Maternal health; Neonatal and Paediatric care. Applications from potential PhD students wishing to work in these areas are welcome.

Biography

Dr Hema Mistry is an Associate Professor in Clinical Trials and Health Economics in the Clinical Trials Unit at Warwick Medical School (WMS). Her current role involves developing a programme of high-quality clinical trials for the maternal health theme. She also works on a number of clinical trials, where she leads the health economics components and supervises junior health economists. She joined the University of Warwick in 2013, working primarily for the Warwick Evidence Technology Appraisal Review team where she jointly led the health economics input into Health Technology Assessment projects for the National Institute of Health and Care Excellence appraisal process. Prior to joining Warwick, she previously worked at the University of Birmingham and at Brunel University. She has an MSc in Health Economics from the University of York and a PhD in Health Economics from Brunel University. She is a Fellow of the Higher Education Academy (HEA) and she lectures on postgraduate modules at WMS. She is a member of the Health Economics Study Group (HESG) and the International Health Economics Association (iHEA).

Title Funder Award start Award end
TAR 3 - Production of Technology Assessment Reviews (TAR) National Institute for Health Research (NIHR DoH) 01 Apr 2022 31 Mar 2027
NIHR HTA researcher led Via Nottingham Univ National Institute for Health Research (DoH) 01 Apr 2019 31 Jul 2023
NIHR HTA Satage 2:What is the comparative clinical and cost- effectiveness of pharmacological treatments for adults with chronic migraine? National Institute for Health Research (NIHR DoH) 01 Sep 2021 28 Feb 2023
NIHR TAR2 12 month extension and supplement - orginal award on IDEATE number 00169 under Aileen Clarke National Institute for Health Research (DoH) 01 Apr 2021 31 Mar 2022
PHE Framework application: Cost-effectiveness of newborn blood spot screening for Tyrosinaemia type 1 using tandem mass spectrometry - an extension Public Health England 08 Jan 2021 31 Jul 2021
NIHR HTA 17/148 - Health Technology Assessment Programme researcher-led evidence synthesis: Determining optimal dietary and physical activity interventions for primary prevention of cardiovascular disease: a global data integration and network meta-analysis National Institute for Health Research (DoH) 01 Feb 2019 31 Jul 2021
NIHR HTA. The clinical effectiveness and cost effectiveness of Surgery for early osteoarthritis of the hip and knee joint via Oxford National Institute for Health Research (DoH) 01 Jun 2019 31 Jan 2021
PGfAR Full application: Chronic Headache Educations and Self-management Study (CHESS): Resubmission National Institute for Health Research (DoH) 05 Jan 2015 31 Oct 2020
DIAMONDS - NIHR HTA recost via Queens University, Belfast (see 41045 for original cost summary.) National Institute for Health Research (DoH) 01 Apr 2016 31 May 2020
Emeralds- recost National Institute for Health Research (DoH) 01 Apr 2017 30 Sep 2019
PHE: PHE:National Screening Committee: Newborn screening for tyrosinaemia type 1: screening and cost-effectiveness Public Health England 01 Mar 2018 28 Feb 2019
Allografts in knee and other joint repairs European Society for Sports Traumatology, Knee Surgery and Arthroscopy (ESSKA) 01 Sep 2017 30 Apr 2018
A Prospective Pilot Study of Home Monitoring in Adults with Cystic Fibrosis (HOME-CF) National Institute for Health Research (DoH) 27 Jul 2015 26 Oct 2017
Acute Kidney Outreach to Reduce Deterioration and Death (AKORDD) - A pilot study to look at enhancing patient care, improving patient outcomes and reducing NHS Costs National Institute for Health Research (DoH) 02 Mar 2014 01 Sep 2016